It has been shown that serum HGF expression is higher in patients with invasive pancreatic cancer, and overexpression of MET is related to more severe invasion into lymph nodes as well as shorter survival, higher recurrence rates, and later stages of tumors [21,22]. The gene discussed is HGF; the disease is familial pancreatic carcinoma.